Age- and gender-associated changes in the concentrations of serum TGF-1β, DHEA-S and IGF-1 in healthy captive baboons (Papio hamadryas anubis)

General and Comparative Endocrinology

Volumn 195, Issue , 2014, Pages 21-27

  Willis, E L ^a   Wolf, R F ^b   White, G L ^b   McFarlane, D ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Aging; Baboon; DHEA S; IGF 1; Non human primates; TGF 1

Indexed keywords

PRASTERONE SULFATE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 3; TRANSFORMING GROWTH FACTOR BETA1;

ADULT ANIMAL; AGING; ARTICLE; BABOON; BLOOD SAMPLING; ENZYME IMMUNOASSAY; FEMALE; HORMONE BLOOD LEVEL; JUVENILE ANIMAL; LONGITUDINAL STUDY; MALE; MEDICAL EXAMINATION; NONHUMAN; PAPIO HAMADRYAS ANUBIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SEX DIFFERENCE; ANIMAL; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE SYSTEM; METABOLISM; PAPIO HAMADRYAS;

AGING; ANIMALS; DEHYDROEPIANDROSTERONE SULFATE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE SYSTEM; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; PAPIO HAMADRYAS; RADIOIMMUNOASSAY; SEX FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84887568800     PISSN: 00166480     EISSN: 10956840     Source Type: Journal    
DOI: 10.1016/j.ygcen.2013.10.004     Document Type: Article

References (53)

1. Attanasio R., Jayashankar L., Engleman C.N., Scinicariello F. Baboon immunoglobulin constant region heavy chains: identification of four IGHG genes. Immunogenetics 2002, 54:556-561.
2. Bartke A. Growth hormone and aging: a challenging controversy. Clinical Interventions in Aging 2008, 3:659-665.
3. Baxter R.C., Butt A.J., Schedlich L.J., Martin J.L. Antiproliferative and pro-apoptotic activities of insulin-like growth factor-binding protein-3. Growth Hormone & IGF Research 2000, 10(Suppl. A):S10-S11.
4. Baylis D., Bartlett D.B., Syddall H.E., Ntani G., Gale C.R., Cooper C., et al. Immune-endocrine biomarkers as predictors of frailty and mortality: a 10-year longitudinal study in community-dwelling older people. Age (Dordrecht, Netherlands) 2013, 35:963-971.
5. Bord S., Beavan S., Ireland D., Horner A., Compston J.E. Mechanisms by which high-dose estrogen therapy produces anabolic skeletal effects in postmenopausal women: role of locally produced growth factors. Bone 2001, 29:216-222.
6. Buford T.W., Willoughby D.S. Impact of DHEA(S) and cortisol on immune function in aging: a brief review. Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition et Metabolisme 2008, 33:429-433.
7. Butt A.J., Williams A.C. IGFBP-3 and apoptosis - a license to kill?. Apoptosis 2001, 6:199-205.
8. Carrieri G., Marzi E., Olivieri F., Marchegiani F., Cavallone L., Cardelli M., et al. The G/C915 polymorphism of transforming growth factor beta1 is associated with human longevity: a study in Italian centenarians. Aging Cell 2004, 3:443-448.
9. Courtland, H.W., Kennedy, O.D., Wu, Y., Gao, Y., Sun, H., Schaffler, M.B. et al., 2012. Low levels of plasma IGF-1 inhibit intracortical bone remodeling during aging. Age (Dordrecht, Netherlands) 35, 1691-1703.
10. Deak F., Sonntag W.E. Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1. The Journals of Gerontology 2012, 67:611-625.
11. Denmeade S.R., Lin X.S., Isaacs J.T. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate 1996, 28:251-265.
12. Ewan K.B., Shyamala G., Ravani S.A., Tang Y., Akhurst R., Wakefield L., et al. Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation. The American Journal of Pathology. 2002, 160:2081-2093.
13. Glazer N.L., Macy E.M., Lumley T., Smith N.L., Reiner A.P., Psaty B.M., et al. Transforming growth factor beta-1 and incidence of heart failure in older adults: the cardiovascular health study. Cytokine 2012, 60:341-345.
14. Hazeldine J., Arlt W., Lord J.M. Dehydroepiandrosterone as a regulator of immune cell function. The Journal of Steroid Biochemistry and Molecular Biology 2010, 120:127-136.
15. Higashi Y., Sukhanov S., Anwar A., Shai S.Y., Delafontaine P. Aging, atherosclerosis, and IGF-1. The Journals of Gerontology 2012, 67:626-639.
16. Hindmarsh P.C., Dennison E., Pincus S.M., Cooper C., Fall C.H., Matthews D.R., et al. A sexually dimorphic pattern of growth hormone secretion in the elderly. The Journal of Clinical Endocrinology and Metabolism 1999, 84:2679-2685.
17. Hou Y.L., Chen H., Dong Z.H., Xue C.J., Wu Y.F., Luo H.X., et al. Clinical significance of serum transforming growth factor-beta1 in lung cancer. Cancer Epidemiology 2013, 37:750-753.
18. Junnila R.K., List E.O., Berryman D.E., Murrey J.W., Kopchick J.J. The GH/IGF-1 axis in ageing and longevity. Nature Reviews 2013, 9:366-376.
19. Kaklamani V.G., Linos A., Kaklamani E., Markaki I., Mantzoros C. Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. Journal of Clinical Oncology 1999, 17:813-817.
20. Kennedy R.C., Shearer M.H., Hildebrand W. Nonhuman primate models to evaluate vaccine safety and immunogenicity. Vaccine 1997, 15:903-908.
21. Khorram O., Vu L., Yen S.S. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. The Journals of Gerontology 1997, 52:M1-7.
22. Kim J.H., Park H.H., Lee C.E. IGF-1 potentiation of IL-4-induced CD23/Fc(epsilon)RII expression in human B cells. Molecules and Cells 2003, 15:307-312.
23. Kimata H., Fujimoto M. Growth hormone and insulin-like growth factor I induce immunoglobulin (Ig)E and IgG4 production by human B cells. Journal of Experimental Medicine 1994, 180:727-732.
24. Kyprianou N., Isaacs J.T. Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death. Molecular Endocrinology (Baltimore, MD) 1989, 3:1515-1522.
25. Labrie F. DHEA, important source of sex steroids in men and even more in women. Progress in Brain Research 2010, 182:97-148.
26. Landin-Wilhelmsen K., Lundberg P.A., Lappas G., Wilhelmsen L. Insulin-like growth factor I levels in healthy adults. Hormone Research 2004, 62(Suppl. 1):8-16.
27. Letterio J.J., Roberts A.B. Transforming growth factor-β1-deficient mice: identification of isoform-specific activities in vivo. Journal of Leukocyte Biology 1996, 59:769-774.
28. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-β. Annual Review of Immunology 1998, 16:137-161.
29. Li C., Levitz M., Hubbard G.B., Jenkins S.L., Han V., Ferry R.J., et al. The IGF axis in baboon pregnancy: placental and systemic responses to feeding 70% global ad libitum diet. Placenta 2007, 28:1200-1210.
30. Lin C.M., Huang Y.L., Lin Z.Y. Influence of gender on serum growth hormone, insulin-like growth factor-I and its binding protein-3 during aging. Yonsei Medical Journal 2009, 50:407-413.
31. Lin Y., Nakachi K., Ito Y., Kikuchi S., Tamakoshi A., Yagyu K., et al. Variations in serum transforming growth factor-beta1 levels with gender, age and lifestyle factors of healthy Japanese adults. Disease Markers 2009, 27:23-28.
32. Maninger N., Wolkowitz O.M., Reus V.I., Epel E.S., Mellon S.H. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Frontiers in Neuroendocrinology 2009, 30:65-91.
33. McFarlane D., Wolf R.F., McDaniel K.A., White G.L. Age-associated alteration in innate immune response in captive baboons. The Journals of Gerontology 2011, 66:1309-1317.
34. Moses H., Barcellos-Hoff M.H. TGF-beta biology in mammary development and breast cancer. Cold Spring Harbor Perspectives in Biology 2011, 3:a003277.
35. Murthy K.K., Salas M.T., Carey K.D., Patterson J.L. Baboon as a nonhuman primate model for vaccine studies. Vaccine 2006, 24:4622-4624.
36. Oberbauer A.M. The regulation of IGF-1 gene transcription and splicing during development and aging. Frontiers in Endocrinology 2013, 4:39.
37. Okamoto Y., Gotoh Y., Uemura O., Tanaka S., Ando T., Nishida M. Age-dependent decrease in serum transforming growth factor (TGF)-β1 in healthy Japanese individuals; population study of serum TGF-β1 level in Japanese. Disease Markers 2005, 21:71-74.
38. Pincus S.M., Gevers E.F., Robinson I.C., van den Berg G., Roelfsema F., Hartman M.L., et al. Females secrete growth hormone with more process irregularity than males in both humans and rats. The American Journal of Physiology 1996, 270:E107-115.
39. Priego T., Ibanez de Caceres I., Martin A.I., Villanua M.A., Lopez-Calderon A. Endotoxin decreases serum IGFBP-3 and liver IGFBP-3 mRNA: comparison between Lewis and Wistar rats. Molecular and Cellular Endocrinology 2003, 199:23-28.
40. Puche J.E., Castilla-Cortazar I. Human conditions of insulin-like growth factor-I (IGF-I) deficiency. Journal of Translational Medicine 2012, 10:224.
41. Roberts A.B., Anzano M.A., Lamb L.C., Smith J.M., Sporn M.B. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proceedings of the National academy of Sciences of the United States of America 1981, 78:5339-5343.
42. Savineau J.P., Marthan R., Dumas de la Roque E. Role of DHEA in cardiovascular diseases. Biochemical Pharmacology 2013, 85:718-726.
43. Shariat S.F., Shalev M., Menesses-Diaz A., Kim I.Y., Kattan M.W., Wheeler T.M., et al. Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy. Journal of Clinical Oncology 2001, 19:2856-2864.
44. Shearer M.H., Dark R.D., Chodosh J., Kennedy R.C. Comparison and characterization of immunoglobulin G subclasses among primate species. Clinical and Diagnostic Laboratory Immunology 1999, 6:953-958.
45. Solerte S.B., Fioravanti M., Vignati G., Giustina A., Cravello L., Ferrari E. Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I. The Journal of Clinical Endocrinology and Metabolism 1999, 84:3260-3267.
46. Sonntag W.E., Ramsey M., Carter C.S. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Research Reviews 2005, 4:195-212.
47. Tarantal A.F., Castillo A., Ekert J.E., Bischofberger N., Martin R.B. Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta). Journal of Acquired Immune Deficiency Syndromes 2002, 29(1999):207-220.
48. Ulijaszek S.J. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the pubertal growth spurt in the female rhesus monkey. American Journal of Physical Anthropology 2002, 118:77-85.
49. Wang X.L., Wang J., Rainwater D.L. Acute effects of insulin-like growth factor-1 and recombinant growth hormone on liporotein(a) levels in baboons. Metabolism: Clinical and Experimental 2002, 51:508-513.
50. Wilson M.E. Insulin-like growth factor I (IGF-I) replacement during growth hormone receptor antagonism normalizes serum IGF-binding protein-3 and markers of bone formation in ovariectomized rhesus monkeys. The Journal of Clinical Endocrinology and Metabolism 2000, 85:1557-1562.
51. Wolf R.F., Papin J.F., Hines-Boykin R., Chavez-Suarez M., White G.L., Sakalian M., et al. Baboon model for West Nile virus infection and vaccine evaluation. Virology 2006, 355:44-51.
52. Young D.G., Skibinski G., Mason J.I., James K. The influence of age and gender on serum dehydroepiandrosterone sulphate (DHEA-S), IL-6, IL-6 soluble receptor (IL-6 sR) and transforming growth factor beta1 (TGF-beta1) levels in normal healthy blood donors. Clinical and Experimental Immunology 1999, 117:476-481.
53. Zhang N., Wu X.Y., Wu X.P., Fu X.H., Du X.Y., Xie H., et al. Relationship between age-related serum concentrations of TGF-beta1 and TGF-beta2 and those of osteoprotegerin and leptin in native Chinese women. Clinica Chimica Acta; International Journal of Clinical Chemistry 2009, 403:63-69.